BA
EXAS

BKS Advisors’s Exact Sciences EXAS Stock Holding History

BKS Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12,850
Closed -$811K – 211
2018
Q4 		$811K Buy
12,850
+2,950
+30% +$202K 0.37% 70
2018
Q3 		$781K Sell
9,900
-400
-4% -$26.1K 0.29% 89
2018
Q2 		$616K Sell
10,300
-5,350
-34% -$288K 0.22% 114
2018
Q1 		$631K Sell
15,650
-4,500
-22% -$220K 0.23% 106
2017
Q4 		$1.06M Buy
20,150
+15,650
+348% +$836K 0.38% 71
2017
Q3 		$212K Buy
+4,500
New +$181K 0.08% 185

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BKS Advisors's EXAS Position: Q1 2019 in Review

BKS Advisors sold out of Exact Sciences (EXAS) in Q1 2019, closing a stake of 12,850 shares — an estimated $811K sold.

BKS Advisors first reported a position in EXAS in Q3 2017 and held it in 6 quarters. The position peaked at $1.06M in Q4 2017. 423 funds tracked by Wall St. Rank hold EXAS as of Q1 2019.

  • BKS Advisors reported no remaining Exact Sciences position as of Q1 2019 after selling out during the quarter.
  • BKS Advisors sold 12,850 Exact Sciences shares in Q1 2019, an estimated $811K.
  • BKS Advisors first reported a position in Exact Sciences in Q3 2017 and held it in 6 quarters.
  • BKS Advisors's Exact Sciences position peaked at $1.06M in Q4 2017.
  • 423 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2019.

Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.